NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin.

Winnie YeoThomas Kh LauCarol Ch KwokKwai T LaiVicky Tc ChanLeung LiVivian ChanAshley WongWinnie Mt SooEva Wm YeungKam H WongNelson Ls TangJoyce Js SuenFrankie Kf Mo

Published in: BMJ supportive & palliative care (2020)

NCT03386617.

Keyphrases

early stage
open label
low dose
drug delivery
high dose
locally advanced
radiation therapy
placebo controlled
breast cancer risk
young adults
study protocol